Are you tired of the he said/she said rants on this message board about Insmed? I certainly understand. Posts are deleted commonly......mostly by the original poster themselves making it difficult to go back and double check something. OR, even more annoying is the reposting of previous posts (and sometimes I may be guilty myself in posting a comment that was deleted along with those deleted posts.....LOL).
So, some of you are probably confused as to the discussion of some things you may or may not even know about. That's why doing some DD may be helpful. Here are some terms that have probably confused you:
Arikayce, INS1009, iPlex, igfbp3, INSM-18, INS-1, ALS, HARS, GHIS/IGFD, patent infringement, Genentech (Roche), Tercica (Ipsen), opt-in, 2018 (some even say late 2017), and more. However, I get so confused sometimes and I'm sure you do as well.
So, DD is going to open a brand new world to you. You can find out as much or as little as you want. But here are some possible side roads to take.......and these are certainly not all of the ways you can go.
1) Arikayce and INS1009 are the present and future (you can get a lot of information by googling or even going to the Insmed website and clicking on their Annual and Quarterly reports)
2) iPlex deals with the past and future for the most part . There is a present comment in the annual report that says "...iPlex is no longer a development priority....". Of course, that is because currently Arikayce is the priority. Many here, myself included, still think a BIG part of Insmed's future lies with iPlex. Try this
I don't know who Dr. Allen is......but there was a Dr. Geoffrey ALLAN who used to be CEO of Insmed. Also, as far as him "dropping" iPlex?????? Nahhhh......it's just on the shelf for a little while.....in fact, for a day shorter than yesterday. But, you probably know that and are just trying to deceive the not so informed here. I find it hard to believe that anyone would take you serious anymore.......I would rather want to know what T TOWE PRICE, FMR, and other institutions think than you
Whoops, sorry I clicked too soon. Try this: Google the following for a historical article about iPlex: Growth Drug Is Caught Up in Patent Fight. This will help you with more information about the past of iPlex and the following terms listed in the previous post.....patent infringement, opt-in, 2018, ALS, HARS, GHIS/IGFD
3) igfbp3 and INSM -18 are possible future indications that have not really begun yet. It would be best to just google some of those terms and Insmed.
4) INS-1 is definitely in Insmed's past as it was discontinued in 2002. I keep hoping it will be resurrected ala WD-40 (LOL)
Some further thoughts and questions
5) Why are almost 90% of Insmed shares owned by institutions (Fidelity, Vanguard, and about 100 more). I may be wrong, but I have a feeling that these institutions have done a lot of dd and know Insmed's past and present very well.....and based on some assumptions due to their dd.....can see some future potential scenarios playing out.
6) Go to Insmed's website and Annual report and read up about some of the officers and especially board members. There is an impressive roster there. A question I continually ask myself is why are they onboard with Insmed.....maybe it's as simple as having the opportunity for some Insmed stock options (LOL). There's some high powered resumes there.
Well, time to go. There is so much more that could be typed here, but I am not really all that knowledgable. There are others here who are much more qualified to impart good information. Trust no one, read everything with a grain of salt, confirm comments with what your own dd is telling you..... everyone has their own agenda....my agenda is to see Insmed's share price appreciate to three figures.....but I won't state it here (surprise....lol)
Best to all
I can post again......8-)
Here is a near term May Calendar for Insmed:
1) Acceptance of six abstracts for poster presentation at the American Thoracic Society (ATS) 2015 International Conference taking place in Denver from May 15 - 20.
2) May 18th.......2015 UBS Global Healthcare Conference
3) May 21st.......Insmed Annual Shareholders Meeting
If someone offered 11.2 billion dollars, I would sell my shares. Some will say that's too high, some will say that's too low.......fro me, it's just right.
......are you interested in reading some backstory on Insmed's iPlex......which currently is not a priority (but hopefully will be in the near future)?
Google the following: INSMED’S (INSM) DRUG IPLEX™: VALUABLE, OR NOT VALUABLE?
There is a pretty good historical article from July 13, 2009. Please note, this is just for historical background information. I hope this is helpful. I always thought it helpful in order to predict and prepare for the future, it is probably best if we know something about it from the past.
.....as of 3/31/15
Here is some information gleaned from the NASDAQ site:
---most everyone is accounted for, minus a couple institutions with a position in the 1st Quarter
---Institutional Ownership is just over 87%.....accounting for just under 53.6 million shares. PLEASE NOTE--this is just Institutions, Insider holdings are not included in this figure
---POINT 72 ASSET sold out their position of 2.8 million shares
---there are several NEW and current institutions that added 6-figure share counts
---T ROWE PRICE added 7.9 million shares for a total of 8.4 million shares (number 2 holder)
---FMR added 1.2 million shares for a total of 8.6 million shares (number 1 holder)
Google the following for a historical article about iPlex: Growth Drug Is Caught Up in Patent Fight
Oh, that's right.......T. Rowe Price bought 7.9 million shares.....not 70.9 million shares.
Yes, I was just kidding........please take a couple deep breaths and relax.
Check out slide 30........this is with regards to projected cash burn for 2015. I don't know if this fully answers your question, but I would rather have more cash on hand than run short or tight.
If I'm not mistaken, the Institutions should be filing their 1st Quarter (March 31) reports by May 15th. That is Friday......so, we should have a better handle as to the percentage held by the Institutions and who owns what soon.
1) Do your own dd on the past and potential future of iPlex (2018 is a key time target to know about)
2) Am I the only one who has observed with delight the venom and angst shown here by some at the mention of iPlex?
3) Management has said publicly that iPlex is "not a priority".......that's it. They don't give a time definition of that comment......so, I interpret it in my own way for that to mean at this time. To me, the vagueness implies that it may be in the future......otherwise management would have inserted a comment like.....ever or never.
4) Common sense tells me that if iPlex is a complete failure "forever", then don't you think Genentech (Roche) and/or Tercica (Ipsen) would have been happy to tell the world that and released Insmed from the terms of the patent infringement settlement and let Insmed have to explain why they weren't moving forward on iPlex? I mean, come on, there is no love lost between Genentech/Tercica and Insmed.
5) Common sense again tells me that it would be unreasonable to think that all of the institutions invested in Insmed haven't done their careful dd and uncovered the past and potential future of iPlex. (Think Fidelity, who if memory serves me correctly, has been invested in Insmed since before Arikayce.
6) I am comfortable in my position with regards to iPlex, no one is going to be able to shake my confidence in waiting for 2018, at least to know what the future holds there..........unless management changes their wording........8-)
......about 150,000 shares.
Avg Daily Share Volume
Days To Cover
6/15/2015 4,737,887 373,575 12.682559
5/29/2015 4,576,408 222,516 20.566647